Clinical Trial Update: [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of [177Lu]-NeoB and [68Ga]-neoB in patients with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• [177Lu]-NeoB
• [68Ga]-neoB

Snippet

Sponsor: Advanced Accelerator Applications | Conditions: Neoplasms | Phase 1, Phase 2 | Status: COMPLETED